Angiographic and clinical outcomes of rosiglitazone in patients with type 2 diabetes mellitus after percutaneous coronary interventions: a single center experience.
about
The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model.Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.A novel polymer-free ciglitazone-coated vascular stent: in vivo and ex vivo analysis of stent endothelialization in a rabbit iliac artery model.Pharmacological prevention and management of restenosis.
P2860
Angiographic and clinical outcomes of rosiglitazone in patients with type 2 diabetes mellitus after percutaneous coronary interventions: a single center experience.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Angiographic and clinical outc ...... s: a single center experience.
@en
Angiographic and clinical outc ...... s: a single center experience.
@nl
type
label
Angiographic and clinical outc ...... s: a single center experience.
@en
Angiographic and clinical outc ...... s: a single center experience.
@nl
prefLabel
Angiographic and clinical outc ...... s: a single center experience.
@en
Angiographic and clinical outc ...... s: a single center experience.
@nl
P2093
P2860
P356
P1433
P1476
Angiographic and clinical outc ...... s: a single center experience.
@en
P2093
Chi-Liang Chen
Ching-Chang Fang
Ching-Lung Yu
Shih-Pu Wang
Yeun Tarl Fresner Ng Jao
P2860
P304
P356
10.1177/0003319707303587
P577
2007-10-01T00:00:00Z